Twynsta 40 mg/5 mg tablets

Company
Boehringer Ingelheim Limited
Active Ingredient
Dosage Form
Tablet
Legal Category
B - prescription, may be renewed

*further information is available on request to the holder of the authorisation or in the SPC

Licence number Strength ATC Code Dosage Form
EU/1/10/648/001 40/5 mg/mg C09DB04 Tablet
EU/1/10/648/002 40/5 mg/mg C09DB04 Tablet
EU/1/10/648/003 40/5 mg/mg C09DB04 Tablet
EU/1/10/648/004 40/5 mg/mg C09DB04 Tablet
EU/1/10/648/005 40/5 mg/mg C09DB04 Tablet
EU/1/10/648/006 40/5 mg/mg C09DB04 Tablet
EU/1/10/648/007 40/5 mg/mg C09DB04 Tablet
Licence number
EU/1/10/648/001
Strength
40/5 mg/mg
ATC Code
C09DB04
Dosage Form
Tablet
Licence number
EU/1/10/648/002
Strength
40/5 mg/mg
ATC Code
C09DB04
Dosage Form
Tablet
Licence number
EU/1/10/648/003
Strength
40/5 mg/mg
ATC Code
C09DB04
Dosage Form
Tablet
Licence number
EU/1/10/648/004
Strength
40/5 mg/mg
ATC Code
C09DB04
Dosage Form
Tablet
Licence number
EU/1/10/648/005
Strength
40/5 mg/mg
ATC Code
C09DB04
Dosage Form
Tablet
Licence number
EU/1/10/648/006
Strength
40/5 mg/mg
ATC Code
C09DB04
Dosage Form
Tablet
Licence number
EU/1/10/648/007
Strength
40/5 mg/mg
ATC Code
C09DB04
Dosage Form
Tablet

Boehringer Ingelheim Limited

The Crescent Building, , Northwood, Santry, Dublin 9

Email
medinfo.ukie@boehringer-ingelheim.com